COLLEEN COLE: Open Payments
NPI 1447234190 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 48 payments from 11 companies in 2025. Trend: 2023 $459 · 2024 $1,027 · 2025 $772
Food & beverage: $579Education: $193
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $274 |
| GlaxoSmithKline, LLC. | 20 | $161 |
| Novo Nordisk Inc | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| GENZYME CORPORATION | 2 | $45 |
| Optinose US, Inc. | 2 | $36 |
| PFIZER INC. | 2 | $35 |
| Amgen Inc. | 1 | $34 |
| ALK-Abello, Inc | 1 | $25 |
| Genentech USA, Inc. | 1 | $18 |
Products named: DUPIXENT, NUCALA, Wegovy, FASENRA, Xhance, PRE-PEN, TRELEGY ELLIPTA, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across OH — which companies pay providers there.
